NCT01681810View on ClinicalTrials.gov

Oral Nitrite in Adults With Metabolic Syndrome and Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 8, 2018

Study Completion Date

March 8, 2018

Conditions
Metabolic SyndromeHypertension
Interventions
DRUG

14Nitrogen Sodium Nitrite

oral formulation of sodium nitrite 40 mg three times a day for 12 weeks

Trial Locations (1)

15213

Montefiore Hospital of University of Pittsburgh Medical Center (UPMC), Pittsburgh

All Listed Sponsors
lead

Gladwin, Mark, MD

INDIV

NCT01681810 - Oral Nitrite in Adults With Metabolic Syndrome and Hypertension | Biotech Hunter | Biotech Hunter